Monument Avenue Pediatrics
Monument Avenue Pediatrics was paid $2.07M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoMONUMENT AVENUE PEDIATRICS
RICHMOND, VA 23230
RICHMOND, VA 23230
33aNPI1831286996assigned 10/09/2006
33bProvider typeSpecialist
28Total paid$2.07M
24GClaims71,855
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Virginia
Rank by total paid#11 of 231
Median peer was paid$47K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,298 | $192K | |
| 2019 | 11,438 | $318K | |
| 2020 | 10,039 | $222K | |
| 2021 | 9,976 | $308K | |
| 2022 | 12,487 | $379K | |
| 2023 | 10,598 | $350K | |
| 2024incomplete | 11,019 | $304K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 12,227 | 11,198 | $674K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 6,059 | 5,726 | $512K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.9% | 2,192 | 2,106 | $163K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.5% | 1,536 | 1,488 | $114K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.5% | 1,763 | 1,445 | $113K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.8% | 2,667 | 2,597 | $80K |
| 92552 | 2.7% | 2,047 | 1,995 | $55K | |
| 90688 | 2.1% | 3,760 | 3,579 | $44K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 2,377 | 1,129 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 2,151 | 2,089 | $28K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 923 | 778 | $28K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 314 | 301 | $25K |
46 more codes
| 99000 | 1.0% | 10,324 | $21K | |
| 87430 | <1% | 1,633 | $20K | |
| 90700 | <1% | 1,679 | $20K | |
| 90670 | <1% | 809 | $19K | |
| 96127 | <1% | 4,593 | $18K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,978 | $14K |
| 90713 | <1% | 919 | $11K | |
| 90648 | <1% | 853 | $9K | |
| 0001A | <1% | 194 | $8K | |
| 90686 | <1% | 527 | $7K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 822 | $6K |
| 0071A | <1% | 139 | $6K | |
| 0002A | <1% | 133 | $5K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 555 | $4K |
| 90658 | <1% | 335 | $4K | |
| 90651 | <1% | 106 | $4K | |
| 0072A | <1% | 94 | $4K | |
| 99173 | <1% | 1,453 | $3K | |
| 90685 | <1% | 219 | $2K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 270 | $2K |
| 0124A | <1% | 65 | $2K | |
| 99070 | <1% | 1,024 | $2K | |
| 99441 | <1% | 122 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 112 | $2K |
| 81002 | <1% | 588 | $2K | |
| 96161 | <1% | 573 | $1K | |
| 0004A | <1% | 33 | $1K | |
| 36416 | <1% | 2,904 | $1K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 84 | $1K |
| 90633 | <1% | 72 | $906.80 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 117 | $840.00 |
| 90677 | <1% | 13 | $805.67 | |
| 90680 | <1% | 59 | $692.13 | |
| 90619 | <1% | 15 | $552.36 | |
| 91320 | <1% | 15 | $421.66 | |
| 0081A | <1% | 14 | $376.00 | |
| 99050 | <1% | 37 | $337.53 | |
| 0082A | <1% | 14 | $236.00 | |
| 90715 | <1% | 13 | $213.60 | |
| 90744 | <1% | 16 | $192.08 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 58 | $159.45 |
| 99177 | <1% | 36 | $149.56 | |
| 94760 | <1% | 81 | $108.28 | |
| 99174 | <1% | 15 | $67.60 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 112 | $19.63 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSOLTYS, GRACE (PRESIDENT)